Get the app!
Back to Trades

Erdogan-Trinkaus Ipek

Chief Commercial OfficerCIK 0002047026

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
4
Buy transactions
0
Sell transactions
2
Companies
1
Active
2025–2026

Erdogan-Trinkaus Ipek, Chief Commercial Officer, accounts for 4 disclosed filings worth $974.6K, all concentrated in Eton Pharmaceuticals, Inc. (ETON), active 2025–2026. The record is heavily weighted toward selling, with $0 in purchases against $235.9K in sales. Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

4 loaded
Nov 12ETON
Eton Pharmaceuticals, Inc.
Erdogan-Trinkaus IpekChief Commercial OfficerSell$235.9K
Aug 4ETON
Eton Pharmaceuticals, Inc.
Erdogan-Trinkaus IpekChief Commercial OfficerAward$0
Jan 14ETON
Eton Pharmaceuticals, Inc.
Erdogan-Trinkaus IpekChief Commercial OfficerAward$628.9K
Dec 12ETON
Eton Pharmaceuticals, Inc.
Erdogan-Trinkaus IpekChief Commercial OfficerTax withheld$1.4K

4 filings